TAFENOQUINE SUCCINATE
UNII DL5J0B8VSS

Substance Identification & Data

This profile provides standardized clinical and technical data for Tafenoquine Succinate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DL5J0B8VSS.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 106635-81-8 and the RxNorm Concept ID (RxCUI) 2054091. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

DL5J0B8VSS

CAS Registry Number

106635-81-8

RxNorm Concept ID

2054091

Detailed Substance Profile

Preferred Name

TAFENOQUINE SUCCINATE

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

DL5J0B8VSS

The specific atomic composition represented as a molecular structure string.

InChIKey

C24H28F3N3O3.C4H6O4

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

CQBKFGJRAOXYIP-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C152489

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

163761

Unique identification number in the NCBI database of chemical substances.

USAN ID

AB-18

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c12c(c(cc(OC)c1Oc3cccc(C(F)(F)F)c3)NC(CCCN)C)nc(OC)cc2C.C(=O)(CCC(=O)O)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tafenoquine Succinate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.